Navigation Links
New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias
Date:9/18/2007

cure rate compared to a 79.8% cure rate seen with the combination of piperacillin/tazobactam. The study also highlighted that resistance to piperacillin/tazobactam in bacteria causing pneumonia was higher than doripenem, especially among strains of Pseudomonas aeruginosa and Klebsiella pneumoniae.

A second study demonstrated that 500 mg of doripenem administered intravenously every eight hours (500 mg IV q8h) was as clinically effective and well tolerated as standard therapy with imipenem given as 500 mg intravenously every six hours (500 mg IV q6h) or 1 g every eight hours (1 g IV q8h) in patients with ventilator-associated pneumonia, including in high-risk patients, such as the elderly. Overall clinical cure rates were 68.3% for doripenem and 64.8% for imipenem. For those patients with Pseudomonas aeruginosa infection, doripenem demonstrated a 65% clinical cure rate compared to a 36% clinical cure rate seen with imipenem.

"These studies demonstrate that doripenem may be effective against a major cause of nosocomial pneumonia, Pseudomonas aeruginosa, which is one of the most difficult bacteria to treat," said Michael Niederman, M.D., Professor of Medicine, State University of New York at Stony Brook and Chairman of the Department of Medicine at Winthrop University Hospital in Mineola, New York. "Additionally, these troubling bacteria demonstrated a low rate of resistance to doripenem, which is an important factor in determining which antibiotic may work most effectively against the infection."

The use of doripenem in the treatment of nosocomial pneumonia, including ventilator-associated pneumonia, is under standard regulatory review in the United States and Europe. These data, along with the regulatory submissions, demonstrate the ongoing commitment of Johnson & Johnson Pharmaceutical Research & Development, L.L.C., to developing novel drugs for the anti-infective market.

Study Results

In a Phase III, open-label, randomized, multi-cent
'/>"/>

SOURCE Johnson & Johnson Pharmaceutical Research & Development,
L.L.C.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
2. Eurands Zentase Effective in Treating Exocrine Pancreatic Insufficiency, Studies Show
3. Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid Arthritis
4. Gabapentin Shown Effective for Fibromyalgia Pain
5. ApoCells Cancer Predictive Index Helps Oncologists Select the Most Effective Targeted Drug Therapy
6. Roxro Pharma’s Novel Intranasal Pain Reliever Effective, Well Tolerated in Phase 3 Study
7. XYOTAX More Cost Effective With Fewer Side Effects Than Gemcitabine or Vinorelbine in Treating Non-Small Cell Lung Cancer
8. Soliris Effective in PNH Patients With History of Aplastic Anemia and Myelodysplastic Syndromes
9. Repeated Radioimmunotherapy With 131I-Labetuzumab Appears Safe and Effective in Colorectal Cancer with Liver Metastases
10. Biotheras Imprime PGG Enhanced Effectiveness of Avastin in Cancer Study
11. Targanta Study Shows Oritavancin Treatment Effective in a Mouse Model of Anthrax
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... , Sept. 18, 2014  ePharmaSolutions, the ... recognized as the Disruptive Innovator of the ... cloud-based eClinical platform. This solution includes an ... master file (eTMF), a remote monitoring application, ... ReferralPlus+ patient screening and matching technology. ...
(Date:9/18/2014)... PLAINSBORO, N.J. , Sept. 18, ... of the National Hemophilia Foundation,s (NHF) new three-year ... support to people with hemophilia and their families/caregivers ... that can impede disease management. The curriculum for ... With Your Provider About Pain , focuses on ...
(Date:9/18/2014)... Australian biomarker discovery company Minomic International Ltd ... MiStat™ prostate cancer screening test, planning to achieve US ... Minomic,s proprietary MiStat™ technology is a screening ... biomarker known as the MIL-38 antigen. This biomarker is ... Researchers at 11 leading urology centres in ...
Breaking Medicine Technology:ePharmaSolutions Named 2014 Disruptive Innovator of the Year for its ePharmaONE eClinical Platform 2ePharmaSolutions Named 2014 Disruptive Innovator of the Year for its ePharmaONE eClinical Platform 3Novo Nordisk Supports National Hemophilia Foundation Initiative for "Collaborating in Care" Disease Management Program 2Novo Nordisk Supports National Hemophilia Foundation Initiative for "Collaborating in Care" Disease Management Program 3Minomic Launches US Pilot Study of MiStat(TM) Novel Prostate Cancer Screening Technology 2
... FAIRPORT, N.Y., March 19, 2012 CooperVision, a leading ... Eighth Annual Global Awards with a "Best ... branding firm Siegel+Gale collaborated with the company on its ... is the first and highest worldwide recognition of its ...
... Therapies, Inc., a development stage biotechnology company focused on ... that it has appointed Duane Nash, MD, JD, MBA, ... Dr. Nash joins Vital Therapies, Inc., from Wedbush PacGrow ... Equity Research. According to STARMINE® / Thomson Reuters, Dr. ...
Cached Medicine Technology:CooperVision Wins 2012 REBRAND 100® Global Award 2Top Ranked Equity Analyst Joins Vital Therapies, Inc. 2
(Date:9/18/2014)... News) -- Rising temperatures in the Atlantic Ocean may ... waters that are becoming warmer, an expansion that could ... A study of 40 species along the reefs ... the invasive and poisonous lionfish, according to researchers from ... University of North Carolina-Wilmington, who published their findings in ...
(Date:9/18/2014)... Steven Reinberg HealthDay Reporter ... that the Ebola outbreak in West Africa is starting to spread ... than 700 new cases of the deadly viral infection were reported ... cases to more than 5,300, with roughly half of those reported ... The number of deaths now tops 2,600. WHO has estimated ...
(Date:9/18/2014)... IL (PRWEB) September 18, 2014 Limited ... fall. , Only 100 spots are still available ... and Operations of ASCs on October 23-25, 2014 at ... Becker's Hospital Review Chief Information Officer Strategy Roundtable on ... Only 25 spots remain for Becker's Hospital Review Chief ...
(Date:9/18/2014)... PRAIRIE, Texas (PRWEB) September 18, 2014 ... for the air medical transport industry, ShandsCair Flight ... Airbus Helicopters Inc . (AHI) at the Air ... , The recently delivered and placed into service ShandsCair ... B4 that will be displayed at AMTC highlight Airbus ...
(Date:9/18/2014)... It is that time of year – time to ... Evensong Spa at Heidel House Resort ... a special $50 rate Oct. 20 through Nov. 1. ... Resorts , is the only Wisconsin destination spa participating in ... and wellness by experiencing affordable spa and wellness treatments. ...
Breaking Medicine News(10 mins):Health News:Rising Atlantic Ocean Temperatures Could Pose Threat to Reefs 2Health News:New Ebola Cases Top 700 in Just One Week, Officials Report 2Health News:New Ebola Cases Top 700 in Just One Week, Officials Report 3Health News:Limited Spots Remain at Becker's Upcoming ASC and Hospital Conferences 2Health News:Airbus Helicopters Inc. Features Industry-leading Models at AMTC 2Health News:Airbus Helicopters Inc. Features Industry-leading Models at AMTC 3Health News:Airbus Helicopters Inc. Features Industry-leading Models at AMTC 4Health News:Evensong Spa Celebrates Spa Week with $50 Services 2Health News:Evensong Spa Celebrates Spa Week with $50 Services 3
... in School-Age Children with Less,Complex Heart Defects, ... does not cause short-term neurological problems in,children and ... to pediatric researchers. The new finding contrasts favorably,with ... surgery for more complex heart conditions., "This ...
... U.S. Families Spend Over $3 Billion Each Year on OTC ... is about to be hit with,runny noses, sore throats and ... in the U.S. that is clinically proven to,shorten the duration ... a naturally-safe cold remedy produced by German pharmaceutical,company, Schwabe, uses ...
... ANTHEM, Ariz., Nov. 11 Prime Companies, Inc.,(Pink Sheets: ... now scheduled for launch by the end of 2008. ... consumers to search for,the dentist of their choice, who ... anticipate revenues to begin to be generated by our ...
... 11 A groundbreaking new study published in,the November ... that eaters of lower energy dense breakfast have improved ... a healthy weight. The,study found that those who enjoy ... richer in important vitamins and minerals and lower in,saturated ...
... Nov. 11 The 14th Annual National Ergonomics,Conference ... Dec. 2 - 5,will be attended by ergonomics, ... international organizations, including: American,Airlines, Bayer, CDC, ExxonMobil, Ford, ... Toyota, US Dept of Labor/OSHA, U.S.,Army and hundreds ...
... of cases, U-M Health Minute: Today,s top health issues ... Bradford Miller,has had diabetes for nine years, and he knows ... and numbness in the feet., "Knowing some of the ... care of those things immediately I knew would prevent larger,issues, ...
Cached Medicine News:Health News:No Drop in I.Q. Seen After Bypass for Child Heart Surgery 2Health News:No Drop in I.Q. Seen After Bypass for Child Heart Surgery 3Health News:Naturally Safe Cold Remedy Challenges Effectiveness of Over-The-Counter Cold Medications 2Health News:Naturally Safe Cold Remedy Challenges Effectiveness of Over-The-Counter Cold Medications 3Health News:Prime Companies Announces Launch of Consumer Dental Service Software 2Health News:Breakfast Improves Overall Diet Quality and May Help with Weight Management 2Health News:Breakfast Improves Overall Diet Quality and May Help with Weight Management 3Health News:2008 National Ergonomics Conference and Expo to Focus on Ways to Increase Productivity and Reduce Spending in the Workplace 2Health News:2008 National Ergonomics Conference and Expo to Focus on Ways to Increase Productivity and Reduce Spending in the Workplace 3Health News:Foot Problems Common Among People With Diabetes 2Health News:Foot Problems Common Among People With Diabetes 3
... a threaded titanium anchor, specifically ... The anchor features wide threads ... optimize bone purchase, as well ... prevent suture binding. Fastin RC ...
... The Rotator Cuff Anchor (RCA), ... for soft tissue reattachment to bone. ... which eliminates the need to predrill ... in fixation is due to subcortical ...
The Mini-Revo suture anchor is designed primarily for arthroscopic and open Bankart shoulder repair. Additional applications include other shoulder repair procedures, as well as use in small joints....
... UltraFix MiniMite Suture Anchor System ... the market that will accept ... surface until deployed eliminates tissue, ... its ultra smooth eyelet hole ...
Medicine Products: